News Center
October 15, 2024
Variantyx Combines Long and Short Reads for Rare Disease Whole-Genome Diagnostic Test
- By Variantyx
- Posted in General Company Updates
GenomeWeb recently wrote a profile on Genomic Unity 2.0® – the first commercially available test to incorporate third-generation long-read Oxford...
September 18, 2024
Variantyx Brings the First Combined Short- and Long-Read Whole Genome Sequencing Test to Market with Genomic Unity® 2.0
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. September 18, 2024 (Business Wire) – Variantyx, a leading molecular diagnostics lab, today announced the launch of Genomic...
May 21, 2024
Longer ZFHX3 repeat lengths correlate with earlier age of onset of SCA4
- By Variantyx
- Posted in Repeat Expansions
For years scientists believed they knew where the causal gene for spinocerebellar ataxia (SCA4) could be found, but the identity...
April 26, 2024
Variantyx Secures $36M Investment As Testing Demand And Market Share Continues To Increase
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. April 26, 2024 (Business Wire) – Variantyx, a leader in molecular diagnostics, announced today that it has secured...
November 30, 2023
Expanded STR Detection Capability Enables Variantyx to Diagnose Additional Genetic Disorders
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. November 30, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced that the set of...
November 10, 2023
Variantyx Expands Its Reproductive Health Offerings with Launch of a Direct Replacement for Chromosomal Microarray Analysis
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. November 10, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced the launch of its...
October 18, 2023
Variantyx Announces Additional Investment Enabling Rapid Expansion of Its Commercial Footprint
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. October 18, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine today, announced that it has secured...
July 28, 2023
PGx testing informs clinical management for cancer patients
- By Variantyx
- Posted in Clinical Education
Somatic testing of solid tumors has become the standard of care. Specific mutations in genes such as BRAF, EGFR, NTRK...
July 7, 2023
Company Spotlight Series: Greice Krautz-Peterson
- By Variantyx
- Posted in Company Spotlight Series
Meet Greice, Associate Director of Germline Assay Development at Variantyx! This inspired me to get an MS and PhD in...
July 5, 2023
Variantyx updates secondary findings reporting policy to ACMG v3.2
- By Variantyx
- Posted in Secondary & Incidental Findings
Just 13 days ago, June 22nd to be exact, the American College of Medical Genetics and Genomics (ACMG) published the...